世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の疥癬治療市場の成長（現状と展望）2024-2030年


Global Scabies Treatment Market Growth (Status and Outlook) 2024-2030

LPI（LPインフォメーション）の最新調査によると、世界の疥癬治療市場規模は2023年に100万米ドルと評価されました。川下市場での需要の増加に伴い、疥癬治療薬はレビュー期間中の年平均成長率（CAGR）で2030年ま... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション 		2024年6月21日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		110 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

LPI（LPインフォメーション）の最新調査によると、世界の疥癬治療市場規模は2023年に100万米ドルと評価されました。川下市場での需要の増加に伴い、疥癬治療薬はレビュー期間中の年平均成長率（CAGR）で2030年までに100万米ドルの再調整規模になると予測されています。
この調査レポートは、世界の疥癬治療市場の成長可能性を明らかにしています。疥癬治療は今後の市場において安定した成長を示すと予測される。しかし、製品の差別化、コストの削減、サプライチェーンの最適化は、疥癬治療薬の普及には引き続き不可欠です。市場プレイヤーは、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供などを行い、疥癬治療市場が提供する膨大な機会を活用する必要があります。
疥癬は、人間の皮膚内に生息する微細なダニSarcoptes scabieiによって引き起こされる感染性皮膚疾患である。
世界の医薬品市場は2022年に1475億ドルに達し、今後6年間は年平均成長率5％で成長する。医薬品市場には化学医薬品と生物学的製剤がある。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。
主な特徴
疥癬治療薬市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長：この調査レポートは、疥癬治療市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分（軟膏、配合剤など）、地域別内訳を含む場合があります。
市場の促進要因と課題：政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、疥癬治療市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。
競合情勢：この調査レポートは、疥癬治療市場内の競合状況の分析を提供します。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興プレーヤーとその潜在的な市場への影響も強調することができます。
技術開発：調査レポートは、疥癬治療業界における最新の技術開発を掘り下げることができます。これには、疥癬治療技術の進歩、疥癬治療の新規参入、疥癬治療の新規投資、疥癬治療の将来を形作るその他の技術革新が含まれます。
川下の事業者の好み：本レポートは、疥癬治療市場における顧客の購買行動や採用動向に光を当てることができます。顧客の購買決定や疥癬治療製品の嗜好に影響を与える要因も含まれています。
政府の政策とインセンティブ：調査レポートは、政府の政策やインセンティブが疥癬治療市場に与える影響を分析します。これには、疥癬治療市場の促進を目的とした規制枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性：調査レポートは、疥癬治療市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望：実施した分析に基づき、調査レポートは疥癬治療産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を行っています。市場関係者が新たなトレンドを活用し、課題を克服し、疥癬治療市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場細分化：
疥癬治療市場はタイプ別と用途別に分類されます。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を提供します。
タイプ別セグメント
軟膏剤
配合剤
その他
用途別セグメント
病院
在宅医療
専門クリニック
その他
本レポートではまた、市場を地域別に分けています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ルネッサンス・ファーマシューティカルズ
メルク・アンド・カンパニー
ランバクシー・ラボラトリーズ・リミテッド
ドクター・スキャビーズ
グラクソ・スミスクライン
ユニケム・ラボラトリーズ・リミテッド
エンキューブ・エシカルズ
BJainグループ
ペリゴ社
キュラティオ・ヘルスケア
アボット・ラボラトリーズ
ニューライフ・ファーマシューティカルズ


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Scabies Treatment Market Size 2019-2030
2.1.2 Scabies Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Scabies Treatment Segment by Type
2.2.1 Ointment
2.2.2 Combinational Medicines
2.2.3 Others
2.3 Scabies Treatment Market Size by Type
2.3.1 Scabies Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Scabies Treatment Market Size Market Share by Type (2019-2024)
2.4 Scabies Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Homecare
2.4.3 Specialty Clinics
2.4.4 Others
2.5 Scabies Treatment Market Size by Application
2.5.1 Scabies Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Scabies Treatment Market Size Market Share by Application (2019-2024)
3 Scabies Treatment Market Size by Player
3.1 Scabies Treatment Market Size Market Share by Players
3.1.1 Global Scabies Treatment Revenue by Players (2019-2024)
3.1.2 Global Scabies Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Scabies Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Scabies Treatment by Regions
4.1 Scabies Treatment Market Size by Regions (2019-2024)
4.2 Americas Scabies Treatment Market Size Growth (2019-2024)
4.3 APAC Scabies Treatment Market Size Growth (2019-2024)
4.4 Europe Scabies Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Scabies Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Scabies Treatment Market Size by Country (2019-2024)
5.2 Americas Scabies Treatment Market Size by Type (2019-2024)
5.3 Americas Scabies Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Scabies Treatment Market Size by Region (2019-2024)
6.2 APAC Scabies Treatment Market Size by Type (2019-2024)
6.3 APAC Scabies Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Scabies Treatment by Country (2019-2024)
7.2 Europe Scabies Treatment Market Size by Type (2019-2024)
7.3 Europe Scabies Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Scabies Treatment by Region (2019-2024)
8.2 Middle East & Africa Scabies Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Scabies Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Scabies Treatment Market Forecast
10.1 Global Scabies Treatment Forecast by Regions (2025-2030)
10.1.1 Global Scabies Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Scabies Treatment Forecast
10.1.3 APAC Scabies Treatment Forecast
10.1.4 Europe Scabies Treatment Forecast
10.1.5 Middle East & Africa Scabies Treatment Forecast
10.2 Americas Scabies Treatment Forecast by Country (2025-2030)
10.2.1 United States Scabies Treatment Market Forecast
10.2.2 Canada Scabies Treatment Market Forecast
10.2.3 Mexico Scabies Treatment Market Forecast
10.2.4 Brazil Scabies Treatment Market Forecast
10.3 APAC Scabies Treatment Forecast by Region (2025-2030)
10.3.1 China Scabies Treatment Market Forecast
10.3.2 Japan Scabies Treatment Market Forecast
10.3.3 Korea Scabies Treatment Market Forecast
10.3.4 Southeast Asia Scabies Treatment Market Forecast
10.3.5 India Scabies Treatment Market Forecast
10.3.6 Australia Scabies Treatment Market Forecast
10.4 Europe Scabies Treatment Forecast by Country (2025-2030)
10.4.1 Germany Scabies Treatment Market Forecast
10.4.2 France Scabies Treatment Market Forecast
10.4.3 UK Scabies Treatment Market Forecast
10.4.4 Italy Scabies Treatment Market Forecast
10.4.5 Russia Scabies Treatment Market Forecast
10.5 Middle East & Africa Scabies Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Scabies Treatment Market Forecast
10.5.2 South Africa Scabies Treatment Market Forecast
10.5.3 Israel Scabies Treatment Market Forecast
10.5.4 Turkey Scabies Treatment Market Forecast
10.5.5 GCC Countries Scabies Treatment Market Forecast
10.6 Global Scabies Treatment Forecast by Type (2025-2030)
10.7 Global Scabies Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Renaissance Pharmaceuticals
11.1.1 Renaissance Pharmaceuticals Company Information
11.1.2 Renaissance Pharmaceuticals Scabies Treatment Product Offered
11.1.3 Renaissance Pharmaceuticals Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Renaissance Pharmaceuticals Main Business Overview
11.1.5 Renaissance Pharmaceuticals Latest Developments
11.2 Merck & Co.
11.2.1 Merck & Co. Company Information
11.2.2 Merck & Co. Scabies Treatment Product Offered
11.2.3 Merck & Co. Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck & Co. Main Business Overview
11.2.5 Merck & Co. Latest Developments
11.3 Ranbaxy Laboratories Limited
11.3.1 Ranbaxy Laboratories Limited Company Information
11.3.2 Ranbaxy Laboratories Limited Scabies Treatment Product Offered
11.3.3 Ranbaxy Laboratories Limited Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ranbaxy Laboratories Limited Main Business Overview
11.3.5 Ranbaxy Laboratories Limited Latest Developments
11.4 Dr. Scabies
11.4.1 Dr. Scabies Company Information
11.4.2 Dr. Scabies Scabies Treatment Product Offered
11.4.3 Dr. Scabies Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Dr. Scabies Main Business Overview
11.4.5 Dr. Scabies Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Scabies Treatment Product Offered
11.5.3 GlaxoSmithKline Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Unichem Laboratories Ltd
11.6.1 Unichem Laboratories Ltd Company Information
11.6.2 Unichem Laboratories Ltd Scabies Treatment Product Offered
11.6.3 Unichem Laboratories Ltd Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Unichem Laboratories Ltd Main Business Overview
11.6.5 Unichem Laboratories Ltd Latest Developments
11.7 Encube Ethicals
11.7.1 Encube Ethicals Company Information
11.7.2 Encube Ethicals Scabies Treatment Product Offered
11.7.3 Encube Ethicals Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Encube Ethicals Main Business Overview
11.7.5 Encube Ethicals Latest Developments
11.8 BJain Group Of Companies
11.8.1 BJain Group Of Companies Company Information
11.8.2 BJain Group Of Companies Scabies Treatment Product Offered
11.8.3 BJain Group Of Companies Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BJain Group Of Companies Main Business Overview
11.8.5 BJain Group Of Companies Latest Developments
11.9 Perrigo Co
11.9.1 Perrigo Co Company Information
11.9.2 Perrigo Co Scabies Treatment Product Offered
11.9.3 Perrigo Co Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Perrigo Co Main Business Overview
11.9.5 Perrigo Co Latest Developments
11.10 Curatio Healthcare
11.10.1 Curatio Healthcare Company Information
11.10.2 Curatio Healthcare Scabies Treatment Product Offered
11.10.3 Curatio Healthcare Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Curatio Healthcare Main Business Overview
11.10.5 Curatio Healthcare Latest Developments
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Information
11.11.2 Abbott Laboratories Scabies Treatment Product Offered
11.11.3 Abbott Laboratories Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Abbott Laboratories Main Business Overview
11.11.5 Abbott Laboratories Latest Developments
11.12 NuLife Pharmaceuticals
11.12.1 NuLife Pharmaceuticals Company Information
11.12.2 NuLife Pharmaceuticals Scabies Treatment Product Offered
11.12.3 NuLife Pharmaceuticals Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NuLife Pharmaceuticals Main Business Overview
11.12.5 NuLife Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

　

ページTOPに戻る


　

Summary

According to our LPI (LP Information) latest study, the global Scabies Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Scabies Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Scabies Treatment market. Scabies Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Scabies Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Scabies Treatment market.
Scabies is an infectious skin disease caused by microscopic mites Sarcoptes scabiei which are foud inside human skin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Scabies Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Scabies Treatment market. It may include historical data, market segmentation by Type (e.g., Ointment, Combinational Medicines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Scabies Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Scabies Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Scabies Treatment industry. This include advancements in Scabies Treatment technology, Scabies Treatment new entrants, Scabies Treatment new investment, and other innovations that are shaping the future of Scabies Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Scabies Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Scabies Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Scabies Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Scabies Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Scabies Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Scabies Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Scabies Treatment market.
Market Segmentation:
Scabies Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Ointment
Combinational Medicines
Others
Segmentation by application
Hospitals
Homecare
Specialty Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Renaissance Pharmaceuticals
Merck & Co.
Ranbaxy Laboratories Limited
Dr. Scabies
GlaxoSmithKline
Unichem Laboratories Ltd
Encube Ethicals
BJain Group Of Companies
Perrigo Co
Curatio Healthcare
Abbott Laboratories
NuLife Pharmaceuticals



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Scabies Treatment Market Size 2019-2030
2.1.2 Scabies Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Scabies Treatment Segment by Type
2.2.1 Ointment
2.2.2 Combinational Medicines
2.2.3 Others
2.3 Scabies Treatment Market Size by Type
2.3.1 Scabies Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Scabies Treatment Market Size Market Share by Type (2019-2024)
2.4 Scabies Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Homecare
2.4.3 Specialty Clinics
2.4.4 Others
2.5 Scabies Treatment Market Size by Application
2.5.1 Scabies Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Scabies Treatment Market Size Market Share by Application (2019-2024)
3 Scabies Treatment Market Size by Player
3.1 Scabies Treatment Market Size Market Share by Players
3.1.1 Global Scabies Treatment Revenue by Players (2019-2024)
3.1.2 Global Scabies Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Scabies Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Scabies Treatment by Regions
4.1 Scabies Treatment Market Size by Regions (2019-2024)
4.2 Americas Scabies Treatment Market Size Growth (2019-2024)
4.3 APAC Scabies Treatment Market Size Growth (2019-2024)
4.4 Europe Scabies Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Scabies Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Scabies Treatment Market Size by Country (2019-2024)
5.2 Americas Scabies Treatment Market Size by Type (2019-2024)
5.3 Americas Scabies Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Scabies Treatment Market Size by Region (2019-2024)
6.2 APAC Scabies Treatment Market Size by Type (2019-2024)
6.3 APAC Scabies Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Scabies Treatment by Country (2019-2024)
7.2 Europe Scabies Treatment Market Size by Type (2019-2024)
7.3 Europe Scabies Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Scabies Treatment by Region (2019-2024)
8.2 Middle East & Africa Scabies Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Scabies Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Scabies Treatment Market Forecast
10.1 Global Scabies Treatment Forecast by Regions (2025-2030)
10.1.1 Global Scabies Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Scabies Treatment Forecast
10.1.3 APAC Scabies Treatment Forecast
10.1.4 Europe Scabies Treatment Forecast
10.1.5 Middle East & Africa Scabies Treatment Forecast
10.2 Americas Scabies Treatment Forecast by Country (2025-2030)
10.2.1 United States Scabies Treatment Market Forecast
10.2.2 Canada Scabies Treatment Market Forecast
10.2.3 Mexico Scabies Treatment Market Forecast
10.2.4 Brazil Scabies Treatment Market Forecast
10.3 APAC Scabies Treatment Forecast by Region (2025-2030)
10.3.1 China Scabies Treatment Market Forecast
10.3.2 Japan Scabies Treatment Market Forecast
10.3.3 Korea Scabies Treatment Market Forecast
10.3.4 Southeast Asia Scabies Treatment Market Forecast
10.3.5 India Scabies Treatment Market Forecast
10.3.6 Australia Scabies Treatment Market Forecast
10.4 Europe Scabies Treatment Forecast by Country (2025-2030)
10.4.1 Germany Scabies Treatment Market Forecast
10.4.2 France Scabies Treatment Market Forecast
10.4.3 UK Scabies Treatment Market Forecast
10.4.4 Italy Scabies Treatment Market Forecast
10.4.5 Russia Scabies Treatment Market Forecast
10.5 Middle East & Africa Scabies Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Scabies Treatment Market Forecast
10.5.2 South Africa Scabies Treatment Market Forecast
10.5.3 Israel Scabies Treatment Market Forecast
10.5.4 Turkey Scabies Treatment Market Forecast
10.5.5 GCC Countries Scabies Treatment Market Forecast
10.6 Global Scabies Treatment Forecast by Type (2025-2030)
10.7 Global Scabies Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Renaissance Pharmaceuticals
11.1.1 Renaissance Pharmaceuticals Company Information
11.1.2 Renaissance Pharmaceuticals Scabies Treatment Product Offered
11.1.3 Renaissance Pharmaceuticals Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Renaissance Pharmaceuticals Main Business Overview
11.1.5 Renaissance Pharmaceuticals Latest Developments
11.2 Merck & Co.
11.2.1 Merck & Co. Company Information
11.2.2 Merck & Co. Scabies Treatment Product Offered
11.2.3 Merck & Co. Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck & Co. Main Business Overview
11.2.5 Merck & Co. Latest Developments
11.3 Ranbaxy Laboratories Limited
11.3.1 Ranbaxy Laboratories Limited Company Information
11.3.2 Ranbaxy Laboratories Limited Scabies Treatment Product Offered
11.3.3 Ranbaxy Laboratories Limited Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ranbaxy Laboratories Limited Main Business Overview
11.3.5 Ranbaxy Laboratories Limited Latest Developments
11.4 Dr. Scabies
11.4.1 Dr. Scabies Company Information
11.4.2 Dr. Scabies Scabies Treatment Product Offered
11.4.3 Dr. Scabies Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Dr. Scabies Main Business Overview
11.4.5 Dr. Scabies Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Scabies Treatment Product Offered
11.5.3 GlaxoSmithKline Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Unichem Laboratories Ltd
11.6.1 Unichem Laboratories Ltd Company Information
11.6.2 Unichem Laboratories Ltd Scabies Treatment Product Offered
11.6.3 Unichem Laboratories Ltd Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Unichem Laboratories Ltd Main Business Overview
11.6.5 Unichem Laboratories Ltd Latest Developments
11.7 Encube Ethicals
11.7.1 Encube Ethicals Company Information
11.7.2 Encube Ethicals Scabies Treatment Product Offered
11.7.3 Encube Ethicals Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Encube Ethicals Main Business Overview
11.7.5 Encube Ethicals Latest Developments
11.8 BJain Group Of Companies
11.8.1 BJain Group Of Companies Company Information
11.8.2 BJain Group Of Companies Scabies Treatment Product Offered
11.8.3 BJain Group Of Companies Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BJain Group Of Companies Main Business Overview
11.8.5 BJain Group Of Companies Latest Developments
11.9 Perrigo Co
11.9.1 Perrigo Co Company Information
11.9.2 Perrigo Co Scabies Treatment Product Offered
11.9.3 Perrigo Co Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Perrigo Co Main Business Overview
11.9.5 Perrigo Co Latest Developments
11.10 Curatio Healthcare
11.10.1 Curatio Healthcare Company Information
11.10.2 Curatio Healthcare Scabies Treatment Product Offered
11.10.3 Curatio Healthcare Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Curatio Healthcare Main Business Overview
11.10.5 Curatio Healthcare Latest Developments
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Information
11.11.2 Abbott Laboratories Scabies Treatment Product Offered
11.11.3 Abbott Laboratories Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Abbott Laboratories Main Business Overview
11.11.5 Abbott Laboratories Latest Developments
11.12 NuLife Pharmaceuticals
11.12.1 NuLife Pharmaceuticals Company Information
11.12.2 NuLife Pharmaceuticals Scabies Treatment Product Offered
11.12.3 NuLife Pharmaceuticals Scabies Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NuLife Pharmaceuticals Main Business Overview
11.12.5 NuLife Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

LP Information社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.